CN105995433A - 一种通便安眠的功能性食品 - Google Patents
一种通便安眠的功能性食品 Download PDFInfo
- Publication number
- CN105995433A CN105995433A CN201610354187.4A CN201610354187A CN105995433A CN 105995433 A CN105995433 A CN 105995433A CN 201610354187 A CN201610354187 A CN 201610354187A CN 105995433 A CN105995433 A CN 105995433A
- Authority
- CN
- China
- Prior art keywords
- parts
- functional food
- sleeping
- rice
- sargassum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013376 functional food Nutrition 0.000 title claims abstract description 25
- 230000000694 effects Effects 0.000 title abstract description 19
- 230000001737 promoting effect Effects 0.000 title abstract description 4
- 230000002040 relaxant effect Effects 0.000 title abstract 3
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 21
- 240000007594 Oryza sativa Species 0.000 claims abstract description 20
- 235000009566 rice Nutrition 0.000 claims abstract description 14
- 239000000203 mixture Substances 0.000 claims abstract description 9
- 239000000843 powder Substances 0.000 claims abstract description 8
- 239000002994 raw material Substances 0.000 claims abstract description 8
- 239000007787 solid Substances 0.000 claims abstract description 7
- 206010010774 Constipation Diseases 0.000 claims description 33
- 241000195474 Sargassum Species 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 15
- 235000007189 Oryza longistaminata Nutrition 0.000 claims description 7
- 235000021329 brown rice Nutrition 0.000 claims description 7
- 241000209094 Oryza Species 0.000 claims 1
- 235000013305 food Nutrition 0.000 abstract description 12
- 230000036541 health Effects 0.000 abstract description 9
- 235000009508 confectionery Nutrition 0.000 abstract description 7
- 235000015097 nutrients Nutrition 0.000 abstract description 3
- 125000003118 aryl group Chemical group 0.000 abstract description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 abstract 1
- 241001474374 Blennius Species 0.000 abstract 1
- 240000000038 Ziziphus mauritiana Species 0.000 abstract 1
- 235000006545 Ziziphus mauritiana Nutrition 0.000 abstract 1
- 235000008529 Ziziphus vulgaris Nutrition 0.000 abstract 1
- 235000007215 black sesame Nutrition 0.000 abstract 1
- 235000004426 flaxseed Nutrition 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 11
- 201000010099 disease Diseases 0.000 description 10
- 239000003814 drug Substances 0.000 description 10
- 210000000952 spleen Anatomy 0.000 description 10
- 239000008280 blood Substances 0.000 description 8
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 206010022437 insomnia Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- 208000007502 anemia Diseases 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 235000016709 nutrition Nutrition 0.000 description 6
- 230000001976 improved effect Effects 0.000 description 5
- 230000035764 nutrition Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000003860 sleep quality Effects 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 238000010792 warming Methods 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 208000005016 Intestinal Neoplasms Diseases 0.000 description 2
- 241000208204 Linum Species 0.000 description 2
- 208000001140 Night Blindness Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 201000002313 intestinal cancer Diseases 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 235000008935 nutritious Nutrition 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010005963 Bone formation increased Diseases 0.000 description 1
- 206010006187 Breast cancer Diseases 0.000 description 1
- 208000026310 Breast neoplasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010062315 Lipohypertrophy Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000007199 Panicum miliaceum Nutrition 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 230000024932 T cell mediated immunity Effects 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 244000022185 broomcorn panic Species 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000357 carcinogen Toxicity 0.000 description 1
- 239000003183 carcinogenic agent Substances 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 description 1
- 230000004719 natural immunity Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000020795 whole food diet Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种通便安眠的功能性食品,其是由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:米200‑400份,海藻4‑7份,黑芝麻20‑50份,亚麻籽20‑50份,大枣40‑70份。本发明采用了较少的纯食材原料所制备的功能性食品,营养丰富,香浓甘醇,固粉混合物,可多次冲泡后食用,老少皆宜,有很高对的养生保健价值,具有显著的通便安眠功效。
Description
技术领域
本发明涉及一种功能性食品,具体涉及一种能够改善便秘失眠人群且养生保健的功能性食品,选用纯天然原产地食材经科学加工配比制成。
背景技术
本发明所述的功能性食品是指具有特定功能的食品,适宜于特定人群食用,可调节机体的功能,又不以治疗为目的的食品,本发明所述的功能性食品适宜于失眠便秘的人群食用。
“药食本同源”是中华原创医学之中对人类最有价值的贡献之一,
中医历来强调“药疗不如食疗”,食物是人类治病最好的药品,食疗就是用食物代替药物而使疾病得到治疗、使细胞恢复功能、使人体恢复健康。高级均衡营养素能增强细胞营养代谢功能,使细胞获得了强大的能量;同时能激活细胞健康免疫基因,使细胞免疫活性增加、免疫细胞的数量成倍增加;能使免疫细胞有能力释放大量的特异性免疫球蛋白直接杀死侵入细胞的细菌病毒,直接中和清除被细胞吸收的物理化学物质;强壮的免疫细胞可直接吞噬病死的细胞和废弃的代谢物,帮助功能低下的细胞恢复功能,以达到治疗疾病的目的。有医药之父之称的希波克拉底说过:药物治疗,不如食物治疗,食物是人类治病的最好药品。他相信人体天赋的自然免疫力是疾病真正的终结者。
现在社会工作、生活压力,精神紧张导致生理反应异常;饮食不规律、现在越来越多医学证据告诉我们,“老化由肠道开始”、“肠癌、乳癌、心脏病、高血压、老年痴呆”等疾病皆与便秘等肠道健康密切相关。尤其是老年人脏腑功能下降,脾气弱,肠蠕动减缓,大肠不畅,导致毒素存留体内,日久可诱发、加重其他疾病如:高血压、高血脂、冠心病、中风、糖尿病、肝炎、肝硬化、胃炎、结肠炎、痔疮、前列腺肥大等,老年人便秘的调理要补脏通腑标本兼调。
睡眠障碍会影响人的学习、记忆、情感等,导致心理疾病的增加,长期睡眠障碍是导致慢性疲劳综合征、高血压病、冠心病、糖尿病、脑血管病的重要原因之一。目前很多失眠患者通常自行服用安眠药来入睡,偶尔服用的确可以使人快速入睡,但长期服用其在体内积聚过多,会引起中毒,对脏器尤其肝肾造成严重损伤,还会导致水牛背、骨质增生等。
目前,虽然不同的功能性食品得到开发并应用于安眠或便秘中,但普遍存在含有中药材、营养单一、治标不治本、高温烘焙造成营养流失的缺点。
发明内容
为解决上述问题,本发明的目的是提供了一种纯食材、营养丰富、高温烘培过程中营养流失非常小、且效果非常显著的通便安眠的功能性食品。
为实现上述目的,本发明采用如下技术方案,一种通便安眠的功能性食品,是由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:
米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
进一步改进技术方案,所述的米是黑米或糙米或红米。
优选地,黑米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
优选地,糙米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
优选地,红米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
根据记载和现代研究证明,本发明的功能性食品各组分的功能是:
( 1 )黑米:性平,味甘,归脾、胃经;
中医认为黑米有显著的药用价值,古农医书记载:黑米“滋阴补肾, 健身暖胃,明目活血”,“清肝润肠”,“滑湿益精,补肺缓筋”等功效;可入药入膳,对头昏目眩、贫血白发、腰膝酸软、夜盲耳鸣症、疗效尤佳。长期食用可延年益寿。因此,人们俗称 :“药米”、“长寿米”。由于它最适于孕妇、产妇等补血之用,又称“月米”、“补血米”等。历代帝王也把它作为宫廷养生珍品,称为“贡米”。现代医学证实,黑米具有滋阴补肾,健脾暖肝、补益脾胃,益气活血,养肝明目等疗效。经常食用黑米,有利于防治头昏、目眩、贫血、白发、眼疾、腰膝酸软、肺燥咳嗽、大便秘结、小便不利、肾虚水肿、食欲不振、脾胃虚弱等症。由于黑米所含营养成分多聚集在黑色皮层,故不宜精加工,以食用糙米或标准三等米为宜。按照营养专家黎黍匀研究,黑米的生命力指数为7.7021,食物防病指数为36.05,具有较强的保健功能。
黑米所含锰、锌、铜等无机盐大都比大米高1-3倍;更含有大米所缺乏的维生素C、叶绿素、花青素、胡萝卜素及强心甙等特殊成分,因而黑米比普通大米更具营养。多食黑米具有开胃益中,健脾暖肝,明目活血,滑涩补精之功,对于少年白发、妇女产后虚弱,病后体虚以及贫血、肾虚均有很好的补养作用。
( 2 )糙米:味甘、性温,健脾养胃、补中益气,调和五脏、镇静神经、促进消化吸收。《本草纲目》中认为,谷芽能消烦、活中、益精、健脾、止泻,对人体十分有益。另外,糙米有提高人体免疫功能,促进血液循环,消除沮丧烦躁的情绪,降低血糖,预防心血管疾病、贫血症、便秘、肠癌等功效。
( 3 )红米:味甘,性温。
红米含有丰富的淀粉与植物蛋白质,可补充消耗的体力及维持身体正常体温。它富含众多的营养素,其中以铁质最为丰富,故有补血及预防贫血的功效。而其内含丰富的磷,维生素A、B群,则能改善营养不良、夜盲症和脚气病等毛病;又能有效舒缓疲劳、精神不振和失眠等症状。所含的泛酸、维生素E、谷胱甘滕胺酸等物质,则有抑制致癌物质的作用,尤其对预防结肠癌的作用更是明显。
(4)海藻:性凉,味甘咸;有清热,生津,通便之功效,可提高人体的免疫功能,促进脂肪代谢、降血脂、降血压、软化血管、增加心肌活力、清火安眠、排毒祛斑,是抗细胞癌变的天然食品,对预防糖尿病、心血管疾病等也有一定作用。
( 5 )大枣:甘,温,归脾、胃经;具有补虚益气、养血安神、健脾和胃等功效,能增强肌力、消除疲劳、扩张血管、增加心肌收缩力、改善心肌营养的作用。有补充钙质,防治遗精,通便等作用。有较强的抑癌、抗过敏作用。
( 6 )黑芝麻:又叫胡麻、油麻、乌麻子,其味甘,性平;对于养血,润肠,益精血,补肝肾,头晕眼花,须发早白、病后脱发、耳鸣耳聋、肠燥便秘有极佳的治疗功效。
( 7 )亚麻籽:别名胡麻子、大胡麻。性味 性平,味甘,润燥,祛风,用于皮肤瘙痒、麻风、眩晕、便秘。
本发明有益效果:
本发明采用了较少的纯食材原料所制备的功能性食品,营养丰富,香浓甘醇,固粉混合物,可多次冲泡后食用,老少皆宜,有很高对的养生保健价值,具有显著的通便安眠功效。
具体实施方式
下面结合给出的实施例,对本发明做进一步说明,但并不局限于此。
实施例1:
一种通便安眠的功能性食品,是由由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:
黑米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
实施例2:
一种通便安眠的功能性食品,是由由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:
糙米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
实施例3:
一种通便安眠的功能性食品,是由由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:
红米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
一般建议,上午冲泡并食用实施例1,下午冲泡并食用实施例2,晚上20点之前冲泡并食用实施例3,这样的搭配对便秘、失眠有非常显著的改善效果。
下面通过具体的病例,表明本发明实施例的服用效果:
(1)徐XX,女,54岁,12年便秘,失眠多梦,早上冲泡并食用本发明的实施例1,下午冲泡并食用本发明的实施例2,晚上20点之前冲泡并食用本发明的实施例3,连续服用1个月后,便秘明显改善,且睡眠质量提高。
(2)张XX,男,60岁,失眠多梦,8年便秘,早上冲泡并食用本发明的实施例1,下午冲泡并食用本发明的实施例2,晚上20点之前冲泡并食用本发明的实施例3,连续服用两周后,便秘明显改善,且睡眠质量提高。
(3)许XX,女35岁,工作压力导致经常失眠,3年便秘,早上冲泡并食用本发明的实施例1,下午冲泡并食用本发明的实施例2,晚上20点之前冲泡并食用本发明的实施例3,连续服用一周后,便秘明显改善,且睡眠质量提高。
由以上所提供的3个病例可以明了,本发明功能性食品,对改善便秘和失眠人群来讲,具有明显的积极意义,而且食用本发明对人体是安全的。
本发明不局限于上述的优选实施例,凡是与本发明具有相同或者相近似的技术方案,均属于本发明的保护范围。
Claims (7)
1.一种通便安眠的功能性食品,其特征在于:是由按下述重量份配比的原料制成的固粉混合物,其原料各组分的重量份如下:
米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
2.根据权利要求1所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:黑米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
3.根据权利要求1所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:糙米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
4.根据权利要求1所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:红米200-400份,海藻4-7份,黑芝麻20-50份,亚麻籽20-50份,大枣40-70份。
5.根据权利要求2所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:黑米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
6.根据权利要求3所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:糙米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
7.根据权利要求4所述的一种通便安眠的功能性食品,其特征在于:其原料各组分的重量份如下:红米300份,海藻5份,黑芝麻22份,亚麻籽22份,大枣51份。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610354187.4A CN105995433A (zh) | 2016-05-25 | 2016-05-25 | 一种通便安眠的功能性食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610354187.4A CN105995433A (zh) | 2016-05-25 | 2016-05-25 | 一种通便安眠的功能性食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105995433A true CN105995433A (zh) | 2016-10-12 |
Family
ID=57094994
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610354187.4A Pending CN105995433A (zh) | 2016-05-25 | 2016-05-25 | 一种通便安眠的功能性食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105995433A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744248A (zh) * | 2008-12-05 | 2010-06-23 | 董嫣妮 | 一种用于缓解失眠的功能性方便粥 |
CN104855956A (zh) * | 2015-04-13 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 失眠医学配方食品 |
CN105533522A (zh) * | 2015-11-30 | 2016-05-04 | 张粹鳞 | 一种增强免疫力祛除口臭和狐臭的食品的制作方法 |
-
2016
- 2016-05-25 CN CN201610354187.4A patent/CN105995433A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101744248A (zh) * | 2008-12-05 | 2010-06-23 | 董嫣妮 | 一种用于缓解失眠的功能性方便粥 |
CN104855956A (zh) * | 2015-04-13 | 2015-08-26 | 劲膳美生物科技股份有限公司 | 失眠医学配方食品 |
CN105533522A (zh) * | 2015-11-30 | 2016-05-04 | 张粹鳞 | 一种增强免疫力祛除口臭和狐臭的食品的制作方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103783382B (zh) | 一种防脱发的保健粥及其制备方法 | |
CN103734813B (zh) | 一种滋补黑发的保健乌鸡食品 | |
CN108323719A (zh) | 一种具有补肾乌发功能的黑色杂粮粉 | |
CN103478389B (zh) | 八宝益智保健糕 | |
CN103689378B (zh) | 一种牛蒡功能性挂面及其制备方法 | |
CN105211863A (zh) | 一种制作姜枣淮山酵素的组合物及其姜枣淮山酵素 | |
CN103610153A (zh) | 一种健脾养生汤及其制作方法 | |
CN104621561A (zh) | 一种泥鳅营养保健粉及其制作方法 | |
CN104621587A (zh) | 一种猪肝营养保健粉及其制作方法 | |
CN106942607A (zh) | 一种用于润肠通便的组合物、含其的食疗冲料及其制备方法 | |
CN105310023A (zh) | 一种保健鳝鱼段 | |
CN105875727A (zh) | 一种玫瑰养颜面包及其制作方法 | |
CN105166653A (zh) | 一种健胃养生红薯粥产品及其制作方法 | |
CN106070808A (zh) | 一种复合饮料及制作方法 | |
CN105995433A (zh) | 一种通便安眠的功能性食品 | |
CN104171964A (zh) | 一种营养保健粥 | |
CN106729584A (zh) | 一种治疗小儿厌食症的中药组合物及其制备方法 | |
CN105410619A (zh) | 一种芡实保健糕点 | |
CN104605381A (zh) | 一种乌鸡营养保健粉及其制作方法 | |
CN104397754A (zh) | 一种保健竹鼠肉肠 | |
CN104351657A (zh) | 核桃仁甜玉米营养粥及制作方法 | |
CN104489773A (zh) | 保健草鱼丸食品 | |
CN103340373A (zh) | 五良保健生力糕及其制作方法 | |
CN114451538A (zh) | 一种女用元食丹及其制备工艺 | |
CN103740562A (zh) | 海狗鞭特补酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161012 |
|
RJ01 | Rejection of invention patent application after publication |